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In the study performed in a group of patients infected with T. gondii, we evaluated Th2 humoral response (IL-5, IL-6, IL-10) and
Th1cellresponse(IL-12,TNF-α).ThestudyobjectivewastoassesstheeﬀectofT. gondii onchosenindicesoftheimmuneresponse.
The study involved 52 women infected with T. gondii (aged 18–42 years) prior to antiparasitic treatment. In all the patients, we
found IgM (index > 0.7) and IgG which exceeded 300IU/ml. The control group (C) consisted of 40 healthy women aged 18–46
years. In the study group (T) and in the control group (C), the levels of IgE, IL-5, IL-6, IL-10, IL-12, and TNF-α were determined.
In our study, T. gondii patients had twofold higher levels of IL-5 and IL-6 as compared to healthy subjects, which seems to conﬁrm
the presence of an inﬂammatory state. We found the level of IL-10 to be ﬁvefold higher in the course of toxoplasmosis than in
healthy controls. The levels of IL-12 and TNF-α were comparable to those observed in healthy controls. The study has revealed
that that patients infected with T. gondii show increased production of the humoral response cytokines, whereas the generation of
the cell response cytokines remains unchanged.
Copyright © 2009 Joanna Matowicka-Karna et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Introduction
Toxoplasma gondii is a ruthless intracellular parasite belong-
ing to Coccidae. T. gondii occurs in three forms: tachyzoites,
bradyzoites (in tissues), and sporozoites. The parasite locates
in the brain, heart, lungs, and most frequently in the lymph
nodes. Toxoplasmosis is a disease aﬀecting 500 million people
worldwide. The seroprevalence varies (from 5% to 90%),
depending on geographical location, age, habit of eating raw
meat or unwashed fruit and vegetables, and general level
of hygiene. The incidence of infections is higher in warmer
and humid climate and increases with age. The disease can
be congenital or acquired [1–4]. The parasite after invading
the human body multiplies inside the cell, causing damage
to the reticuloendothelial system. Rapid multiplication of
the parasite and formation of the so-called pseudocysts are
characteristics of the acute phase of invasion [5].
In parasitic invasions, an increase is observed in the
production of IgE antibodies, especially in helminth infec-
tions. This defect results from disturbances in the regula-
tion of antibody production by Th cells, which promotes
local inﬂammatory reaction. Via release of mediators from
mast cells IgE participates in the reaction of antibody-
dependent cellular cytotoxicity (ADCC). Cytotoxic activity
of eosinophils is increased under the inﬂuence of cytokines
(TNF-α and IL-5) released by mast cells, lymphocytes,
and macrophages [6]. Th2 lymphocytes synthesize speciﬁc
cytokines (IL-4, IL-5, IL-6, IL-10, IL-13, and IL-14), which
play a major role in the pathogenesis of parasitic diseases.
IL-5 is the major cytokine responsible for the increase in the
eosinophilpopulationinparasitoses,whereasIL-6stimulates
productionofantibodiesandexertsaproinﬂammatoryeﬀect
by stimulating the generation of acute phase proteins. IL-
10 and IL-12 control the type of the immune response.
The former inhibits cytokine synthesis and by blocking
the production of IL-6 and TNF-α causes an advantage of
the response occurring with Th2 involvement and B cell
activation.However,IL-12facilitatesformationofaTh1type
response [7–10].
In the current study, performed on a group of patients
infected with T. gondii,we evaluated humoral response (IL-
5, IL-6, IL-10 secreted by Th2 cells) and cell response (IL-122 Clinical and Developmental Immunology
and TNF-α secreted by Th1 cells). The study objective was to
assess the eﬀect of T. gondii on chosen indices of the immune
response.
2.MaterialsandMethods
The study involved 52 women infected with T. gondii
(aged 18–42 years) prior to antiparasitic treatment. All
these women had swollen cervical and nuchal lymph nodes
(toxoplasmic lymphadenopathy), although other diseases
were excluded (mononucleosis, cytomegaly, granulomatosis,
lymphomas, leukemias, AIDS). Tests were performed in the
women who were not able to conceive. In all the patients
(group T), the levels of speciﬁc IgM and IgG antibodies,
directedagainstT.gondii,weredetermined.Inallthewomen,
IgM was present (index > 0.7) and the level of IgG exceeded
300IU/ml. The diagnosis of the early phase of T. gondii
infection was based on the detection of a signiﬁcant increase
in the levels of speciﬁc IgG antibodies of low avidity, with
the co-occurrence of IgM antibodies. Assays were performed
using ELFA on an immunoserological analyzer VIDAS with
a set of reagents (bioMerieux). The control group (C)
consisted of 40 healthy women aged 18–46 years, clinically
asymptomatic, who underwent prophylactic examinations
and had no anti-T. gondii speciﬁc antibodies.
The levels of IgE, IL-5, IL-6, IL-10, IL-12, and TNF-α
were determined in the study group (T) and in the control
group (C).
2.1. Determination of Total IgE. Total IgE level was deter-
mined in 100μl serum samples by ELFA (bioMerieux,
France) on an immunoserological analyzer VIDAS. The
sensitivity threshold of the method is 0.5KIU/l.
2.2. Determination of the Levels of Interleukins (IL-5, IL-6, IL-
10, IL-12) and TNF-α. The levels of interleukins and TNF-α
were determined in blood serum using ELISA method with a
set of Quantikine human (R&D, USA).
The results were subjected to statistical analysis using
the program Statistica 8.0. The diﬀerences were considered
statistically signiﬁcant when the value of test function was
at the level of signiﬁcance set at P<. 05. The Kolgomorov
consistency test was used for features consistent with normal
distribution, the t-Student test for comparisons between the
groups and the Mann-Whitney test for traits inconsistent
with this distribution.
3. Results
In patients infected with T. gondii the mean IgE level was
74.7±105.5IU/l,beingtwiceashighasthemeanIgEvaluein
healthyindividuals(37.7±27.6IU/l).Thediﬀerencebetween
these values is statistically signiﬁcant (P<. 05).
The mean level of IL-5 in T. gondii infection was
7.02 ± 2.9pg/ml. However, in healthy subjects, the IL-5
concentration was markedly lower (mean 3.5 ± 1.6pg/ml).
The diﬀerence between these values is statistically signiﬁcant
(P<. 0001).
The mean level of IL-6 in T. gondii-infected patients was
5.21 ± 3.5pg/ml, being twice as high as the mean value in
healthy controls (2.45 ± 1.4pg/ml). The diﬀerence in the
values of IL-6 between the infected and healthy subjects is
statistically signiﬁcant (P<. 0001).
The level of IL-10 was found to be most highly diﬀerenti-
ated. In the course of toxoplasmosis its mean level was 4.50 ±
2.9pg/ml whereas in healthy controls only 0.76 ± 0.2pg/ml.
The diﬀerence between these values is highly statistically
signiﬁcant (P<. 0001). However, a comparison of the mean
levels of IL-12 and TNF-α between T. gondii patients and
healthy subjects did not reveal any statistically signiﬁcant
diﬀerences (0.4 <P<. 5).
4. Discussion
The prevalence of T. gondii has been reported to increase
with age (>40 years) and in women consuming raw meat,
vegetables, and fruit [11]. In the acute phase, directly after
invading the body, T. gondii begins to multiply rapidly. In
am a j o r i t yo fc a s e s ,a c q u i r e dtoxoplasmosis is asymptomatic.
In the second week of infection, speciﬁc IgM antibodies are
present in the blood. IgE antibodies also appear at the same
time, slightly preceding speciﬁc IgA antibodies, but they are
not found 4 months after the infection onset [12]. In our
study,theconcentrationofIgEantibodiesinpatientsinfected
with T. gondii was statistically signiﬁcantly higher than in
healthy subjects, which was accompanied by an elevated level
of IgM antibodies, thus suggesting an acute form of invasion.
Increased IgE level correlates with early acute inﬂammation
or with a reactive form of toxoplasmosis.H o w e v e r ,n e g a t i v e
IgE test result does not exclude acute toxoplasmosis [13]. Dzi-
ubek et al. [14] who determined speciﬁc antibodies directed
against T. gondii (IgM, IgG, IgA) and CD4+ and CD8+ lym-
phocytesubpopulationsfoundmoresubstantialinvolvement
of CD8+, whereas lower expression of CD4+ lymphocytes
might be due to a suppressive action of the parasite.
The humoral response involves IL-5 and IL-6 that exert
a proinﬂammatory eﬀect and IL-10 inhibiting the action
of IL-6. Patients infected with T. gondii had twofold higher
values of IL-5 as compared to healthy subjects. IL-5 prolongs
eosinophil survival, stimulates eosinophil degranulation
and production of reactive oxygen species, and exerts a
chemotactic eﬀect on these cells [15]. It has been proved
that Toxocara canis invasion promotes release of IL-5, IL-
8, and TNF-α, which is accompanied by eosinophilia with
an inﬂammatory state [16]. However, Nickdel et al. [17]
have shown that at the early stage of T. gondii infection,
coexisting with eosinophilia and increased level of IL-5,
pathological changes are prominent in the small intestine,
which is accompanied by a simultaneous reduction in IL-
12 and IFN-γ. We also noted an increase in the level of IL-5
and a decrease in the level of IL-12. However, Filisetti and
Candolﬁ [18] revealed an IL-5 induced increase in IL-12
production in toxoplasmosis. A decrease in the production of
IL-12 and inhibition of Th1 response have been reported by
Lang et al. [7].
In our study, T. gondii patients had a twofold higher
level of IL-6 as compared to healthy subjects, which seems
to conﬁrm the presence of an inﬂammatory state. The majorClinical and Developmental Immunology 3
function of IL-6 is the involvement in the immune response
through the action on lymphocytes B. It is a mediator
responsible for the production of acute phase proteins and
increased cytotoxic activity of NK cells. IL-6 is an early
and sensitive, although nonspeciﬁc, marker of inﬂammatory
states.
We found the level of IL-10 to be ﬁvefold higher in the
course of toxoplasmosis than in healthy controls. Therefore,
we could have expected a decrease in IL-6 production, which
was however not found. IL-10 plays an essential role in
the inﬂammatory response during acute T. gondii infection,
since it inhibits the cellular-type immune response (IL-12,
TNF-α) and inﬂammatory response (IL-6) [17, 19]. IL-10
counteractstheharmfuleﬀectsoftheinﬂammatoryresponse
whichisbasedontheincreasedproductionofTNF-α,IFN-γ,
and NO associated with intestinal multiplication of T. gondii
[20]. IL-10 is able to deactivate macrophages, induce IFN-
γ by T. gondii, and facilitate intracellular parasite survival.
IL-10inducesimmunosuppressionduringT. gondii invasion,
which is beneﬁcial both for the host and the parasite [7].
Also the cellular response, involved among others IL-12
and TNF-α, plays an important role in parasitic invasions.
In our patients infected with T. gondii, the levels of IL-12
and TNF-α were comparable to those observed in healthy
controls. IL-12 was found to increase the production of
IgG but not to inhibit IgE. IFN-γ, IL-2, and IL-12 are
involved in the protection against parasitic invasions. IL-12
stimulates the production of IFN-γ and TNF-α and activates
lymphocyte cytotoxicity [1]. Involvement of IFN-γ and IL-
10 in the immune mechanisms directed against T. gondii has
been described by Kang et al. [21]. According to Filisetti
and Candolﬁ [18], secretion of IFN-γ in mice increases the
phagocytic activity of macrophages and cytotoxic activity
of CD8+T lymphocytes. Increased production of IFN-γ is
strongly correlated with parasite virulence and enhanced
apoptosis.
In our study, in the course of toxoplasmosis the levels of
TNF-α and IL-12 did not change, whereas the concentration
of IL-5 increased. However, as reported by Lang et al. (2007)
T. gondii inhibits production of TNF-α and IL-12. TNF-α
is a cytokine of inﬂammatory and immune response and
together with IL-6 can enhance proliferation and diﬀeren-
tiation of B lymphocytes [7]. TNF-α activates eosinophil
cytotoxicity toward protozoa and induces secretion of acute
phase proteins via IL-6 production. TNF-α and IFN-γ have
antiproliferative properties. In toxoplasmosis, TNF-α appears
tobeindispensableformacrophageactivationandinhibition
of parasite replication; however, this is possible only in
cooperation with IFN-γ.
The study has revealed that patients infected with T.
gondii show increased production of the cytokines respon-
sible for humoral response, whereas generation of the cell
response cytokines remains unchanged.
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